Sanofi Plans $2.6 Billion Counterbid For Zentiva
PARIS (Reuters) - French drugmaker Sanofi-Aventis <SASY.PA>
plans to make a 40.04 billion crown ($2.57 billion) offer for
Czech drugmaker Zentiva <ZNTVsp.PR>, trumping a bid from
financial group PPF.